Brief: Enzychem Lifesciences Announces Filing Of U.S. Provisional Patent For Ec-18 For The Treatment Of Covid-19
10/04/2020 16:05
April 10 (Reuters) - Enzychem Lifesciences Corp 183490.KQ :
* ENZYCHEM LIFESCIENCES ANNOUNCES FILING OF U.S. PROVISIONAL
PATENT FOR EC-18 FOR THE TREATMENT OF COVID-19
Source text for Eikon: ID:nPn980pJ5a
Further company coverage: 183490.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enzychem Lifesciences
See all newsBrief: Enzychem Lifesciences To Divest 8 Billion Won Worth Of Own Shares
Brief: Enzychem Lifesciences Announces Completion Of Clinical Study Report (Csr) For Phase 2 Study Of Ec-18 In Chemoradiation-Induced Oral Mucositis
South Korea's Enzychem to make Indian drugmaker Cadila's COVID-19 shot (updated)
Brief: Cadila Healthcare Inks Deal With South Korea's Enzychem For Plasmid DNA Vaccine
South Korea's Enzychem to make Indian drugmaker Cadila's COVID-19 shot